Hosted on MSN9mon
Senator slams GlaxoSmithKline over cost of asthma inhalers
Pharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a key senator charged Wednesday, in the latest effort by Democrats to pressure drug companies on the ...
Punchng on MSN5mon
Fake, unregistered asthma inhalers flood markets after GSK’s exit
A year after British pharmaceutical giant, GlaxoSmithKline exited Nigeria and asthmatic patients who depended on its inhalers ...
pharmaphorum7d
GSK says new inhaler will help slash its carbon footprint
GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
pharmaphorum7y
GSK and Propeller prepare to launch digital inhaler
Having begun working together in December 2015, the partners are now ready to bring to market their custom digital sensor for GSK’s asthma and COPD inhaler, Ellipta. The sensor attaches to the ...
Drugmaker GSK buys US firm focused on gastro cancer
British pharmaceutical company GSK on Monday said it had agreed to buy a US company that specializes in the treatment of rare ...
E&E1mon
Drug company: We won’t charge more for ‘green’ inhalers
The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...
BBC6y
GSK director sued over US opioid crisis
GSK declined to "comment on legal matters faced ... General's concern about the opioid crisis" and that its "opioid medications account for less than 2% of total opioid prescriptions".